EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
EMEIS SA
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
The current stock price of ORP.PA is 12.465 EUR. In the past month the price decreased by -11.26%. In the past year, price decreased by -99.32%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.18B | ||
EMEIS.PA | EMEIS SA | 1.08 | 1.09B | ||
RHK.DE | RHOEN-KLINIKUM AG | 21.94 | 984.31M | ||
CLARI.PA | CLARIANE SE | N/A | 840.82M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 14.05 | 481.67M | ||
M12.DE | M1 KLINIKEN AG | 17.59 | 293.62M | ||
LNA.PA | LNA SANTE | 9.36 | 234.55M | ||
MED.DE | MEDICLIN AG | N/A | 142.50M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 101.50M | ||
MAK.DE | MATERNUS-KLINIKEN AG | N/A | 36.28M | ||
EIF.DE | MEDNATION AG | 1.29 | 4.12M |
Orpea SA engages in the operation of geriatric healthcare facilities. The company is headquartered in Puteaux, Ile-De-France and currently employs 76,160 full-time employees. The company went IPO on 2002-04-16. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
EMEIS SA
12 Rue Jean Jaures, Puteaux Cedex
Puteaux ILE-DE-FRANCE FR
Employees: 76160
Company Website: https://www.orpea.com/
Phone: 33147757807
The current stock price of ORP.PA is 12.465 EUR.
The exchange symbol of EMEIS SA is ORP and it is listed on the Euronext Paris - Matif exchange.
ORP.PA stock is listed on the Euronext Paris - Matif exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ORP.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ORP.PA.
ORP.PA does not pay a dividend.
ORP.PA will report earnings on 2024-07-24.
The PE ratio for ORP.PA is 1.2. This is based on the reported non-GAAP earnings per share of 10.36 and the current share price of 12.465 EUR.
ChartMill assigns a technical rating of 1 / 10 to ORP.PA. When comparing the yearly performance of all stocks, ORP.PA is a bad performer in the overall market: 96.95% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA. While ORP.PA is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months ORP.PA reported a non-GAAP Earnings per Share(EPS) of 10.36. The EPS decreased by 360.39% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 26.07% | ||
ROA | 9.74% | ||
ROE | 71.82% | ||
Debt/Equity | 4.3 |
ChartMill assigns a Buy % Consensus number of 49% to ORP.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 99.7% and a revenue growth 6.41% for ORP.PA